Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of Inflammation Research|August 13, 2024
Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast CancerYu Qiu, Yan Chen, Haoyang Shen, et al.Frontiers in Oncology|June 26, 2024
Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohortYu Qiu, Yan Chen, Haoyang Shen, et al.Alternative Therapies in Health and Medicine|September 29, 2023
Clinical Efficacy of Neoadjuvant Chemotherapy plus Modified Radical Mastectomy for Stage II-III Breast Cancer Patients and Its Influence on Serum Tumor MarkersShuixin Yan, Jiadi Li, Jiafeng Chen, et al.Scientific Reports|October 12, 2023
Causal effects of genetically predicted endometriosis on breast cancer: a two-sample Mendelian randomization studyShuixin Yan, Jiadi Li, Jiafeng Chen, et al.Journal of Translational Medicine|January 23, 2014
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumorsYu Gu, Tianxiang Chen, Elena López, et al.Scientific Reports|October 20, 2019
Predictors for malignancy risk in subcentimeter thyroid nodules categorized as atypia/follicular lesion of undetermined significance by fine needle aspirationJinhua Ding, Li Jiang, Jianjiang Fang, et al.Iranian Journal of Basic Medical Sciences|November 29, 2018
Silencing of rhomboid domain containing 1 to inhibit the metastasis of human breast cancer cells in vitroChunjun Huang, Xiaochun Ji, Yinyin Peng, et al.Frontiers in Oncology|May 14, 2023
"Elastic stretch cavity building" system in endoscopic thyroidectomy via the axillary approach: a case seriesGaoxiang Chen, Xiaochun Ji, Hai Zhang, et al.ACS Sensors|March 13, 2026
Precision Delineation of Surgical Margins across Breast Cancer Subtypes with a Novel KIAA1363-Targeted NIR Fluorescent ProbeChangyu Zhang, Ziwei Xu, Weizhu Wu, et al.Cancer|April 28, 2020
Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencingJiaojiao Zhou, Honglian Wang, Fangmeng Fu, et al.Pageof 4